Latest Articles
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer - The AI Journal
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer The AI Journal
Published: Dec. 22, 2025, 7:31 a.m.
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer - itemonline.com
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer itemonline.com
Published: Dec. 22, 2025, 7:30 a.m.
Jessie J says going vegan helped ease her endometriosis symptoms – here’s what changed - Women's Health
Jessie J says going vegan helped ease her endometriosis symptoms – here’s what changed Women's Health
Published: Dec. 22, 2025, 6:01 a.m.
New Combination Therapy Shows Promise for pMMR Advanced Endometrial Cancer in Phase Ib/II Trial - geneonline.com
New Combination Therapy Shows Promise for pMMR Advanced Endometrial Cancer in Phase Ib/II Trial geneonline.com
Published: Dec. 21, 2025, 12:34 p.m.
Adenosarcoma of the uterine cervix – a novel case report and review of the literature - Termedia
Adenosarcoma of the uterine cervix – a novel case report and review of the literature Termedia
Published: Dec. 21, 2025, 8:41 a.m.
Why OrthoPediatrics Corp. stock appeals to dividend seekers - Market Risk Analysis & AI Based Buy and Sell Signals - Улправда
Why OrthoPediatrics Corp. stock appeals to dividend seekers - Market Risk Analysis & AI Based Buy and Sell Signals Улправда
Published: Dec. 20, 2025, 10:57 a.m.
Why OrthoPediatrics Corp. stock appeals to dividend seekers - Market Risk Analysis & AI Based Buy and Sell Signals - ulpravda.ru
Why OrthoPediatrics Corp. stock appeals to dividend seekers - Market Risk Analysis & AI Based Buy and Sell Signals ulpravda.ru
Published: Dec. 20, 2025, 10:57 a.m.
Onconic Therapeutics wins IND approval for phase 1b–2 gastric cancer trial in Korea - CHOSUNBIZ - Chosunbiz
Onconic Therapeutics wins IND approval for phase 1b–2 gastric cancer trial in Korea - CHOSUNBIZ Chosunbiz
Published: Dec. 17, 2025, 1:04 a.m.
Pearsanta Initiates Study of Blood-Based Diagnostic for Endometriosis - Medical Product Outsourcing
Pearsanta Initiates Study of Blood-Based Diagnostic for Endometriosis Medical Product Outsourcing
Published: Dec. 15, 2025, 8:33 p.m.
Phase 3 RUBY Trial: Dostarlimab Combination Prolongs Time to Next Treatment for Endometrial Cancer - Cancer Nursing Today
Phase 3 RUBY Trial: Dostarlimab Combination Prolongs Time to Next Treatment for Endometrial Cancer Cancer Nursing Today
Published: Dec. 15, 2025, 8:24 p.m.
Link copied to clipboard!